Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 5, 2021Journal of Nuclear MedicineOpen Access

Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

RNRyusuke NakamotoLZLisa C. ZabaTLTie Liang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nakamoto et al. (2021) studied this question.

synapsesocial.com/papers/6aaa653497e8ffc3eb2ab215https://doi.org/10.2967/jnumed.120.254482
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Longitudinal FDG-PET Revealed Regional Functional Heterogeneity of Bone Marrow, Site-Dependent Response to Treatment and Correlation with Hematological Parameters2015 · 20 citations
  2. 2Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy2019 · 20 citations
  3. 3Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive <i>in vivo</i> <sup>18</sup>F-FDG-PET2019 · 62 citations